Open Access Critical Evidence Review

Hyperbaric oxygen treatment increases intestinal stem cell proliferation via the mTORC1/S6K1 signaling pathway in Mus musculus - Evidence review

In mice, twenty sessions of hyperbaric oxygen therapy increased intestinal stem cell proliferation and mTORC1/S6K1 signaling, without measurable changes in two energy-related enzymes. Independent studies confirm that this pathway can support protein synthesis and stem cell growth, but the effects depend on the cell type and context.

Cite this article
Mondini, M. (2026). Hyperbaric oxygen treatment increases intestinal stem cell proliferation via the mTORC1/S6K1 signaling pathway in Mus musculus - Evidence review. Life Science Hub Journal. DOI: 10.5281/zenodo.24307642. https://lifesciencehub.info/en/hyperbaric-oxygen-treatment-increases-intestinal-stem-cell-proliferation-via-the-mtorc1-s6k1
LIFE Science Hub - Journal of Science · 2026 / Nov

DOI 10.5281/zenodo.24307642

Article history
Dates
  • Published 17/11/2026
  • Updated 17/11/2026
Revisions
  1. v1.0 — 17/11/2026 Initial publication of the article.

LIFE Science Hub keeps a record of every published version of the article to ensure editorial transparency. Future revisions will appear here.

Mouse intestinal crypts with proliferating stem cells, illuminated in a scientific context that evokes hyperbaric oxygen therapy and mTORC1/S6K1.
Intestinal crypts in a bright scientific environment, with visual references to cell proliferation and the mTORC1/S6K1 pathway. The image translates the link between hyperbaric oxygen therapy and increased stem cell activity in the murine model into an editorial format.

ABSTRACT

The analyzed study evaluated whether hyperbaric oxygen therapy, i.e., the administration of pure oxygen at high pressure, could modify the behavior of intestinal stem cells in mice. After twenty sessions, the authors observed an increase in proliferating cells in the intestinal crypts, along with changes consistent with greater involvement of the mTORC1/S6K1 pathway. No differences emerged in the activity of two enzymes used as indirect indicators of oxidative metabolism.

In the narrative of “The Choice to Live in Health or Illness” by Dr. A. Colonnese and R. Panzironi, the publication contributes to the passage stating that the mTORC1-S6K1 axis can promote proliferation through biosynthetic programs, rather than through a simple increase in energy production. Independent studies in mouse models confirm that the activation of mTORC1 and S6K1 in intestinal stem cells can increase protein synthesis and regenerative activity. However, other research shows that the effect of the pathway varies between active stem cells, reserve stem cells, and crypt support cells. The confirmation is therefore primarily mechanistic and does not demonstrate a clinical effect of hyperbaric oxygen therapy in healthy humans.

Analyzed study

Hyperbaric oxygen treatment increases intestinal stem cell proliferation through the mTORC1/S6K1 signaling pathway in Mus musculus

Casanova-Maldonado I, Arancibia D, Lois P, Peña-Villalobos I, Palma V

Biological research, 2023

DOI: 10.1186/s40659-023-00444-3

PMID: 37438828

PMCID: PMC10339527

The research question was whether hyperbaric oxygen therapy could increase the proliferation of intestinal stem cells and whether this effect was associated with the mTORC1/S6K1 pathway. mTORC1 is a protein complex that integrates information on nutrients, growth factors, and environmental conditions; S6K1 is a downstream target protein that contributes to increasing the production of proteins necessary for cell growth.

The relevance to paragraph 4.7 lies in the fact that the study examines, in a rapidly renewing tissue, the link between mTORC1/S6K1 pathway signals and cell proliferation. In the narrative of “The Choice to Live in Health or Illness” by Dr. A. Colonnese and R. Panzironi, the publication is used to argue that the selective activation of this axis can promote a proliferative response without it being explained simply by an increase in energy production.

The study can show experimental associations in the duodenum of young male mice subjected to a specific exposure protocol. It cannot establish that the same effect occurs in the human intestine, that it improves an intestinal disease, or that increased proliferation is always beneficial. Furthermore, the expression of pathway genes and the phosphorylation of S6K1 are important biological indicators, but they do not by themselves constitute a complete measure of protein synthesis or functional tissue regeneration.

Materials and methods of the original study

The authors stated that they used 46 three-month-old male BALB/c mice. However, the experimental groups described in the text include a total of 40 animals: four groups of five animals to compare control and hyperbaric oxygen therapy for 10 or 20 days, plus four groups of five animals for the rapamycin experiment. This numerical discrepancy is not clarified in the available material.

Each session involved 100% oxygen, a pressure of 2 atmospheres absolute, and a total duration of 90 minutes: 15 minutes of compression, 60 minutes at the set pressure, and 15 minutes of decompression. The animals received either 10 or 20 daily sessions. In the pharmacological groups, rapamycin, a drug that inhibits mTORC1, was administered intraperitoneally at 2 mg/kg every other day for 20 days; the comparison group received DMSO, the drug vehicle.

One hour after the last session, the animals received bromodeoxyuridine, or BrdU, a molecule that incorporates into the DNA of dividing cells. In the duodenum, the authors measured BrdU-positive cells per crypt and their co-localization with Olfm4, a marker for intestinal stem cells. They also performed immunohistochemistry and immunofluorescence, quantitative PCR to measure gene expression, western blot to detect phosphorylated S6K1, and enzymatic assays for citrate synthase and cytochrome c oxidase.

Statistical analyses included permutation tests and Kolmogorov-Smirnov tests to compare the distribution of proliferating cells. For some experiments, sample sizes of three, four, or five animals per group are reported. No long-term follow-up data, direct measurements of global protein synthesis, functional tests of intestinal regeneration after injury, or direct measurements of cellular oxygen consumption are reported.

Results

The main result was an increase in proliferation in the duodenal crypts after 20 days of treatment, but not after 10 days. Crypts are small structures at the base of the intestinal mucosa where stem cells and progenitor cells reside. The number of BrdU-positive cells per crypt was higher in the group treated for 20 days compared to the control, with significance reported by the authors as P<0.05 and five animals per group.

The co-localization of BrdU with Olfm4 indicated that a portion of the cells entering division consisted of intestinal stem cells. The authors also observed an increase in the total number of cells in the crypt and in BrdU-positive cells not identified by Olfm4. Therefore, the treatment may have also involved progenitor cells or other stem cell populations, but this attribution was not directly demonstrated.

Regarding the mechanism, after 20 sessions, the levels of messenger RNA for Mtor, Skar, Eef2, and ribosomal protein S6 increased; the reported P values were 0.02, 0.02, 0.01, and less than 0.05, respectively, with five animals per group. In simple terms, these results are consistent with greater activation of a program that promotes protein production and cell growth. Conversely, no significant differences emerged for Eif4e, associated with another branch of mTORC1, nor for Foxo1, used by the authors as an indicator of the mTORC2/SGK1 branch.

In the comparison with rapamycin, the drug reduced the phosphorylation of S6K1, i.e., the activated form of the protein. The combination of rapamycin and hyperbaric oxygen therapy showed the presence of phosphorylated S6K1, with no significant differences compared to the groups with DMSO. However, the association between hyperbaric treatment and activation of the mTORC1/S6K1 axis is based primarily on gene expression and this pharmacological experiment, not on a complete quantification of the phosphorylation of all nodes of the pathway in animals treated with oxygen alone.

Finally, no significant differences were detected in the activity of citrate synthase or cytochrome c oxidase, two enzymes linked to oxidative metabolism, in samples of three animals per group. This indicates that the treatment did not modify these two indicators in the analyzed duodenal tissue. However, it does not demonstrate the absence of any change in energy metabolism, because cellular energy production can also be regulated by other enzymes, substrates, and processes that were not measured.

Interpretation

For the non-specialist reader, the key finding is that in the mouse model, the increased oxygen availability was not accompanied by a measurable increase in two energy-related enzymes, while it was accompanied by greater proliferation of crypt cells and signals consistent with the involvement of mTORC1/S6K1. This makes it biologically plausible to interpret that the proliferative response depends primarily on cell-building programs, including protein synthesis, rather than a simple acceleration of energy production.

The chain of events documented by the publication subject to the Evidence Review is: hyperbaric exposure → modulation of the mTORC1/S6K1 axis → increased proliferation in intestinal crypts. The absence of changes in citrate synthase and cytochrome c oxidase adds an element consistent with the statement in the book, but does not allow for the conclusion that energy plays no role in the cellular response.

The strength of the inference is limited by the animal model, the small sample sizes, and the fact that an increase in messenger RNA does not necessarily equate to an increase in protein activity. Furthermore, mTORC1 and S6K1 have effects that depend on cell type, duration of activation, nutrient availability, and the presence of tissue damage. The study therefore supports a specific mechanistic step in the narrative, not a general rule that activating mTORC1/S6K1 always promotes intestinal health.

Independent supporting evidence

Direct confirmation of the mTORC1/S6K1 → protein synthesis → intestinal stem cell increase pathway comes from an independent experiment on caloric restriction in mice. Igarashi and Guarente observed that, in intestinal stem cells, SIRT1 promoted the deacetylation of S6K1 and increased its phosphorylation by mTORC1. This increase was associated with greater protein synthesis and an increase in the number of intestinal stem cells. Rapamycin abolished the expansion observed in that model [1]. The study does not concern hyperbaric oxygen therapy, but it confirms the central biological link of the paragraph: S6K1 activated downstream of mTORC1 can translate into a biosynthetic and proliferative program.

A second mouse study showed that refeeding after a short Fasting period increased the proliferation of Lgr5-positive intestinal stem cells and their regenerative capacity. The authors attributed this effect to a strong induction of mTORC1, which increased protein synthesis through polyamine metabolism; inhibition of mTORC1, polyamine production, or protein synthesis eliminated the regenerative effect [2]. This evidence is independent and reinforces the sequence mTORC1 → increased protein synthesis → greater stem cell activity. The relevant limitation is that the model was refeeding after Fasting, not exposure to hyperbaric oxygen; furthermore, the same proliferation was associated with an increase in tumorigenicity in predisposed mice.

Regarding the more upstream event, i.e., the possibility that hyperbaric oxygen therapy is associated with greater proliferative activity in the intestinal mucosa, a small prospective series in patients with refractory ulcerative colitis reported, after hyperbaric treatment, a significant increase in the labeling index for PCNA in CD44-positive cells of the colonic mucosa, along with clinical and histological improvement [3]. PCNA is an indicator of cells engaged in the cell cycle and CD44 can identify crypt populations, but it is not equivalent to the Olfm4 marker used in the mouse study. Furthermore, the series lacked a control group and did not measure mTORC1 or S6K1. Therefore, it offers only indirect and preliminary confirmation of the relationship between hyperbaric treatment and proliferative activity in human mucosa.

Conflicting evidence

Important contextual evidence comes from a study on reserve intestinal stem cells, which are less active cells that can contribute to regeneration following injury. In this mouse model, caloric restriction reduced mTORC1 in reserve stem cells and protected them from DNA damage; conversely, stimulation of mTORC1 increased their sensitivity to radiation and impaired regeneration after injury [4].

This finding does not deny that mTORC1/S6K1 activation can support proliferation and protein synthesis in active stem cells. However, it shows that the biological effect is not uniform: it can vary according to the cell population, the timing of the response, and the presence of stress or injury. In particular, what promotes rapid expansion in active stem cells may not protect a reserve population exposed to genomic damage.

No directly conflicting evidence sufficiently relevant to test the same hyperbaric oxygen therapy protocol, the same duodenal region, and the same mTORC1/S6K1 axis in an independent model has been identified; this does not prove the absence of contrary results.

Summary table of evidence

The table distinguishes the original study from independent publications and shows that the convergence primarily concerns the biological mechanism, not a general clinical effect of hyperbaric oxygen therapy.

Reference Study type Population or model Main result Direction of evidence Strength of evidence
Original study Experimental animal Male BALB/c mice, duodenum Twenty hyperbaric sessions increased crypt proliferation and signals consistent with mTORC1/S6K1, with no changes in citrate synthase and cytochrome c oxidase. direct confirmation moderate
[1] Animal, intestinal cells and organoids Mouse intestinal stem cells and Paneth cells mTORC1 and S6K1 increased protein synthesis and the number of intestinal stem cells during caloric restriction. direct confirmation moderate
[2] Animal and organoids Mouse Lgr5-positive intestinal stem cells after fasting and refeeding mTORC1 induction increased protein synthesis, proliferation, and regenerative capacity; inhibition of the pathway abolished the effect. direct confirmation moderate
[3] Prospective observational without control Patients with refractory ulcerative colitis After hyperbaric oxygen therapy, proliferative signals in CD44-positive cells of the colonic mucosa increased. indirect confirmation preliminary
[4] Animal, genetic and pharmacological Mouse reserve intestinal stem cells Reduction of mTORC1 protected reserve cells from damage; its stimulation increased vulnerability to radiation. discordant evidence moderate

Confirmation of the evidence

Claim in the book

In section 4.7 of "The Choice to Live in Health or Illness" by Dr. A. Colonnese and R. Panzironi, the relevant statement is that, in the intestinal epithelium, the selective activation of the mTORC1-S6K1 axis promotes the synchronized proliferation of intestinal stem cells and that this response depends primarily on biosynthetic programs regulated by S6K1, rather than a simple increase in energy production.

Hyperbaric oxygen therapy → mTORC1/S6K1 modulation → biosynthetic programs and protein synthesis → increased proliferation in intestinal crypts, without measured changes in two oxidative enzymes

The publication subject to the Evidence Review was used in the book to support the following passage: in the mouse duodenum, a protocol of twenty hyperbaric oxygen therapy sessions is associated with a synchronized increase in proliferation in the crypts, including Olfm4-positive cells, and with signals compatible with the modulation of the mTORC1/S6K1 axis, with no differences detected in citrate synthase and cytochrome c oxidase activity.

The correspondence with the section of “The Choice to Live in Health or Illness” by Dr. A. Colonnese and R. Panzironi is specific: the original study is not used to demonstrate the entire biology of mTORC1 or the effect of insulin in humans, but to document in vivo a segment of the mTORC1/S6K1 chain → proliferation of intestinal crypt cells. Its observation of the absence of differences in two oxidative enzymes also supports, with caution, the idea that the response is not attributable solely to an increase in the measured oxidative capacity.

Independent evidence primarily consolidates the downstream segment of the chain. In murine intestinal stem cells, the activation of mTORC1 and the phosphorylation of S6K1 have been linked to increased protein synthesis and an increase in the number of stem cells [1]. In a different mouse model, the strong induction of mTORC1 after refeeding increased protein synthesis and the proliferation of intestinal stem cells; inhibition of the pathway eliminated these effects [2]. A small clinical series also suggests that hyperbaric oxygen therapy may be associated with greater proliferative activity in the human colonic mucosa, but it does not identify the mTORC1/S6K1 pathway and does not allow for robust causal inferences [3].

Confirmation, however, requires an essential distinction. In reserve intestinal stem cells subjected to radiation damage, higher mTORC1 activity was found to be unfavorable to survival and regeneration, while its reduction was protective [4]. The book's narrative is therefore well-supported for the proliferation and biosynthesis segment in active intestinal cells, but it should not be automatically extended to all stem cell populations, all damage conditions, or clinical practice.

Overall level of confirmation

MECHANISTIC CONFIRMATION

The original publication and two independent studies in mice converge on the link between mTORC1/S6K1 activity, protein synthesis, and increased intestinal stem cell activity. Evidence in humans for hyperbaric oxygen therapy and this specific mechanism remains limited, indirect, and lacks adequate controlled studies.

Conclusions

The study analyzed provides experimental evidence in mice showing that twenty sessions of hyperbaric oxygen therapy increase proliferation in intestinal crypts and modify indicators of the mTORC1/S6K1 axis. The result is consistent with the idea that S6K1 participates in biosynthetic programs capable of supporting cell growth and division.

Independent research convincingly confirms, in mouse models, that mTORC1 and S6K1 can increase protein synthesis and the activity of intestinal stem cells. However, the significance of this pathway depends on the cell population and the biological situation: its activation is not automatically favorable during tissue damage or in every regenerative context.

The book's narrative is therefore supported at a mechanistic level. Independent validation of the effect of hyperbaric oxygen therapy on the mTORC1/S6K1 pathway in the human intestine remains necessary, through controlled studies that measure both proliferation and clinically relevant outcomes.

Overall assessment

The link between mTORC1/S6K1, protein synthesis, and intestinal stem cell proliferation is fairly well supported in murine models. Its application to hyperbaric oxygen therapy is promising but remains moderately supported, as it is derived primarily from a single animal study and indirect human data, without clinical mechanistic verification.

References

[1] mTORC1 and SIRT1 Cooperate to Foster Expansion of Gut Adult Stem Cells during Calorie Restriction

Igarashi M, Guarente L, 2016

Cell

[2] Short-term post-fast refeeding enhances intestinal stemness via polyamines

Imada S, Khawaled S, Shin H, Meckelmann SW, Whittaker CA, Corrêa RO, et al., 2024

Nature

[3] Hyperbaric oxygen therapy stimulates colonic stem cells and induces mucosal healing in patients with refractory ulcerative colitis: a prospective case series

Bekheit M, Baddour N, Katri K, Taher Y, El Tobgy K, Mousa E, 2016

BMJ Open Gastroenterology

[4] Calorie Restriction Governs Intestinal Epithelial Regeneration through Cell-Autonomous Regulation of mTORC1 in Reserve Stem Cells

Yousefi M, Nakauka-Ddamba A, Berry CT, Li N, Schoenberger J, Bankler-Jukes D, et al., 2018

Stem Cell Reports

Editorial note

Artificial Intelligence was used solely as a tool to support editorial and documentary work. All content, interpretations, bibliographic citations and conclusions have been verified, reviewed and approved by the author, who assumes full scientific responsibility for them.

The manuscript was also subject to independent peer review prior to publication.

To ensure maximum transparency, the article's complete history — including the dates of submission, review, acceptance and publication, as well as information on the peer review process — is available on the dedicated Article History page.